Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Hancock Jaffe Laboratories

Hancock Jaffe Laboratories (HJLI) Stock Overview

Explore Hancock Jaffe Laboratories’s financial performance, market position, analyst ratings, and future outlook.

HJLI●NASDAQ
HealthcareMedical - Devices
$10.38
$0.21(1.98%)
U.S. Market opens in 2h 22m

Hancock Jaffe Laboratories (HJLI)

Meyka AI Score

Z

Key Financials

Market Cap98.3M
P/E Ratio-0.24
EPS (TTM)N/A
ROE-0.62%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HJLI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Hancock Jaffe Laboratories (NASDAQ: HJLI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Hancock Jaffe Laboratories's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HJLI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Hancock Jaffe Laboratories's NASDAQ-traded stock include a P/E ratio of -0.24 and a market capitalization of 98.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HJLI on the NASDAQ.

Price Performance (NASDAQ: HJLI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
99.23%
3-Year Change
-44.79%
5-Year Change
-92.08%
All-Time (Max) Change
-92.08%

Contact Information

http://www.hancockjaffe.com
19492612900
70 Doppler, Irvine, CA, 92618

Company Facts

190 Employees
IPO DateMay 31, 2018
CountryUS

Frequently Asked Questions